Literature DB >> 17448776

Neuroglial disorders of central and peripheral nervous systems in a patient with Hirschsprung's disease carrying allelic SOX10 truncating mutation.

Takashi Shimotake1, Shin-ichiro Tanaka, Rui Fukui, Shigeru Makino, Rikken Maruyama.   

Abstract

BACKGROUND/
PURPOSE: Recent biologic studies have revealed that enteric neuroglial deficiency causes gut functional deterioration. We studied the central and peripheral nervous systems in a SOX10 mutation-associated Hirschsprung's patient who presented persistent gut functional disorders even after definitive surgery.
METHODS: DNA sequences of all coding regions of the SOX10 gene (22q13) were determined using the direct DyeDeoxy Terminator Cycle method, and brain magnetic resonance images, nerve conduction velocities, and histopathology of the enteric nervous system were investigated for neurologic assessment.
RESULTS: DNA analysis revealed a heterozygous nucleotide deletion (778delG) in SOX10 exon 5, causing a frameshift at codon 260 and resulting in premature transcriptional termination at codon 285. Neurologic studies disclosed brain hypomyelination, peripheral dysmyelinating neuropathy, and enteric neuroglia deficiency, which exclusively implied systemic glial maldevelopment.
CONCLUSION: These results suggest that the enteric nervous system in patients with SOX10-associated Hirschsprung's disease is entirely subject to neuroglial impairment. This may explain persistent gut motility and absorption insufficiency after pull-through surgery, especially in children with allelic SOX10 truncating mutations.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17448776     DOI: 10.1016/j.jpedsurg.2006.12.003

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  4 in total

Review 1.  Sox proteins in melanocyte development and melanoma.

Authors:  Melissa L Harris; Laura L Baxter; Stacie K Loftus; William J Pavan
Journal:  Pigment Cell Melanoma Res       Date:  2010-04-22       Impact factor: 4.693

2.  SOX10 transactivates S100B to suppress Schwann cell proliferation and to promote myelination.

Authors:  Sayaka Fujiwara; Shinya Hoshikawa; Takaaki Ueno; Makoto Hirata; Taku Saito; Toshiyuki Ikeda; Hiroshi Kawaguchi; Kozo Nakamura; Sakae Tanaka; Toru Ogata
Journal:  PLoS One       Date:  2014-12-23       Impact factor: 3.240

Review 3.  Peripheral nerve disease secondary to systemic conditions in children.

Authors:  Jo M Wilmshurst; Robert A Ouvrier; Monique M Ryan
Journal:  Ther Adv Neurol Disord       Date:  2019-08-12       Impact factor: 6.570

Review 4.  Sorting Sox: Diverse Roles for Sox Transcription Factors During Neural Crest and Craniofacial Development.

Authors:  Elizabeth N Schock; Carole LaBonne
Journal:  Front Physiol       Date:  2020-12-08       Impact factor: 4.566

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.